Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Laboratories Announces Key Senior Leadership Appointment

Date: 08/03/2016

Hilleman Laboratories Announces Key Senior Leadership Appointment

New Delhi, 8th April, 2016: Hilleman Laboratories, a first-of-its-kind joint-venture partnership between Merck & Co. and Wellcome Trust, today announced the appointment of Dr. Sudeep Singh Gadok as Senior Vice President - Enterprise Development. In this role, Dr. Gadok is entrusted with a dynamic portfolio which includes fostering strategic partnerships, resource development, fundraising and communications. Dr. Gadok joins Hilleman Laboratories from Save the Children, where he was the Director of Programs for India, leading all the technical, thematic and programme operations & management teams.

Pleased to make the announcement, Dr. Davinder Gill, Chief Executive Officer, Hilleman Laboratories said, “This year is really exciting for us at Hilleman Labs as we expect many of our initiatives to advance to the next stage. Dr. Gadok joining us at this opportune juncture adds tremendous value. He comes with excellent credentials and the right skill set to further our organisational development. I am thrilled to have him as a part of the team and believe that he will be integral to our success.”

“Diversity, excellence and impact are constant threads through the various leadership roles that I have held thus far. It’s been my pursuit to turnaround challenging mandates specifically meant to better public health outcomes and I am extremely humbled to be able to work with some of the brightest minds in the industry at Hilleman Labs. I believe that the research and innovations undertaken here, aimed at addressing unmet needs of some of the most under-served nations and communities in the world are truly revolutionary and look forward to be a part of this exciting journey,” Dr. Gadok said.

With over 16 years of experience in global health & health care management, Dr. Gadok has held several leadership roles both internationally and in India. His expertise lies in business strategy, organizational development, management and operations. Apart from leading programmes at the Save the Children, India; Dr. Gadok has worked on vaccine and immunisation programme with both the World Health Organistion as well as UNICEF. Previouly, he was also the CEO of Tulsi Chanrai Foundation in Nigeria, Country Director, India for Project HOPE and was leading the Health Portfolio for Sir Ratan Tata Trust.

About Hilleman Laboratories

Hilleman Laboratories is a first-of-its-kind joint-venture partnership formed between MSD, a global research-driven pharmaceutical organization and Wellcome Trust, a global charitable foundation dedicated to human and animal health by supporting the brightest minds.

Hilleman Laboratories has been named after renowned scientist and father of modern vaccines Dr. Maurice Hilleman. His dedication to making a difference through the practical application of vaccine research and delivering vaccines to people in need forms the core mission of Hilleman Laboratories.

Operating on a not-for-profit principle, Hilleman Laboratories aims to become a preferred partner for Low Cost Vaccine Manufacturers and the ‘global voice’ for vaccine development and usage for public health in the developing world. For further information please visit:

View All